NYU Treatment Center Gets Face Lift
The 38-year-old Dysautonomia Treatment and Evaluation Center at the New York University Medical Center has, in a few months’ time, undergone a vast expansion.
Between November 2007 and this past February, the space the center occupies doubled, the center’s staff more than doubled and the equipment used was “really enhanced,” according to center director Felicia Axelrod.
Dysautonomia is a general term used to describe dysfunction of the autonomic nervous system. It can be caused by a number of diseases. More specifically, one of these disorders, familial dysautonomia, is an inherited progressive neurogenetic disorder that affects the sensory and autonomic nervous systems. Patients suffering with it experience “autonomic crises” that may include cyclical vomiting, life-threatening episodes of high blood pressure and increased heart rate, and sweating with fever. They often have lung and kidney problems. While the center originally focused on FD, it also receives requests to see patients with other types of dysautonomia.
Axelrod said the expansion came about as a “natural evolution,” aided by the discovery of the FD gene in 2001, improving therapies for patients.
As a result of these efforts, she said, FD patients are living longer. Thanks to these efforts, she said, FD patients are maturing and creating an adult population that has the disease, rather than dying early deaths. David Brenner, executive director of the Dysautonomia Foundation (the leading funder of the center), estimated that the average lifespan of an FD patient has risen to between 30 and 40 years, up from five years a few years ago.
The center is the only one of its kind in the United States.
A message from our CEO & publisher Rachel Fishman Feddersen
I hope you appreciated this article. Before you move on, I wanted to ask you to support the Forward’s award-winning journalism during our High Holiday Monthly Donor Drive.
If you’ve turned to the Forward in the past 12 months to better understand the world around you, we hope you will support us with a gift now. Your support has a direct impact, giving us the resources we need to report from Israel and around the U.S., across college campuses, and wherever there is news of importance to American Jews.
Make a monthly or one-time gift and support Jewish journalism throughout 5785. The first six months of your monthly gift will be matched for twice the investment in independent Jewish journalism.
— Rachel Fishman Feddersen, Publisher and CEO
